Cytotoxic T-cell antagonism in HIV-1

The cytotoxic T-cell (CTL) response to human immunodeficiency virus Type 1 (HIV-1) is vigorous and sustained, but despite this, the virus persists. Natural variation arising within CTL epitopes may affect CTL recognition of infected targets and allow viral escape. Some of these variant epitopes appe...

Full description

Bibliographic Details
Main Authors: Klenerman, P, Phillips, R, McMichael, A
Format: Journal article
Language:English
Published: 1996
_version_ 1797103460545462272
author Klenerman, P
Phillips, R
McMichael, A
author_facet Klenerman, P
Phillips, R
McMichael, A
author_sort Klenerman, P
collection OXFORD
description The cytotoxic T-cell (CTL) response to human immunodeficiency virus Type 1 (HIV-1) is vigorous and sustained, but despite this, the virus persists. Natural variation arising within CTL epitopes may affect CTL recognition of infected targets and allow viral escape. Some of these variant epitopes appear to engage T-cell receptors but fail to activate the CTL normally. This can interfere with recognition of the unmutated epitope - a phenomenon known as T-cell antagonism. We discuss the evidence for this in HIV-1 using CTL and epitope variants derived from infected donors, and discuss its possible relevance in vivo.
first_indexed 2024-03-07T06:20:26Z
format Journal article
id oxford-uuid:f2892f70-d7bd-4cae-b5bb-8e336678f95b
institution University of Oxford
language English
last_indexed 2024-03-07T06:20:26Z
publishDate 1996
record_format dspace
spelling oxford-uuid:f2892f70-d7bd-4cae-b5bb-8e336678f95b2022-03-27T12:04:34ZCytotoxic T-cell antagonism in HIV-1Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f2892f70-d7bd-4cae-b5bb-8e336678f95bEnglishSymplectic Elements at Oxford1996Klenerman, PPhillips, RMcMichael, AThe cytotoxic T-cell (CTL) response to human immunodeficiency virus Type 1 (HIV-1) is vigorous and sustained, but despite this, the virus persists. Natural variation arising within CTL epitopes may affect CTL recognition of infected targets and allow viral escape. Some of these variant epitopes appear to engage T-cell receptors but fail to activate the CTL normally. This can interfere with recognition of the unmutated epitope - a phenomenon known as T-cell antagonism. We discuss the evidence for this in HIV-1 using CTL and epitope variants derived from infected donors, and discuss its possible relevance in vivo.
spellingShingle Klenerman, P
Phillips, R
McMichael, A
Cytotoxic T-cell antagonism in HIV-1
title Cytotoxic T-cell antagonism in HIV-1
title_full Cytotoxic T-cell antagonism in HIV-1
title_fullStr Cytotoxic T-cell antagonism in HIV-1
title_full_unstemmed Cytotoxic T-cell antagonism in HIV-1
title_short Cytotoxic T-cell antagonism in HIV-1
title_sort cytotoxic t cell antagonism in hiv 1
work_keys_str_mv AT klenermanp cytotoxictcellantagonisminhiv1
AT phillipsr cytotoxictcellantagonisminhiv1
AT mcmichaela cytotoxictcellantagonisminhiv1